Alessia Bignucolo

Messina, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Exploratory and Pioneering Study on Courses Involving Complementary and Alternative Medicine (CAM) Within an Integrative Approach at University of Messina Medical School.

Exploratory and Pioneering Study on Courses Involving Complementary and Alternative Medicine (CAM) Within an Integrative Approach at University of Messina Medical School.

Journal: Integrative cancer therapies

Published: August 14, 2026

Investigating the Impact of Fusobacterium nucleatum on Oxidative Stress, Chemoresistance, and Inflammation in Inflammatory Bowel Disease and Colorectal Cancer: Rationale and Design of a Clinical Trial.

Investigating the Impact of Fusobacterium nucleatum on Oxidative Stress, Chemoresistance, and Inflammation in Inflammatory Bowel Disease and Colorectal Cancer: Rationale and Design of a Clinical Trial.

Journal: International journal of molecular sciences

Published: June 24, 2025

Multidisciplinary Integrative Medicine Approach for Cancer Patients: A Multicenter Retrospective Study.

Multidisciplinary Integrative Medicine Approach for Cancer Patients: A Multicenter Retrospective Study.

Journal: Nutrients

Published: February 23, 2025

Oxidative Stress by H2O2 as a Potential Inductor in the Switch from Commensal to Pathogen in Oncogenic Bacterium Fusobacterium nucleatum.

Oxidative Stress by H2O2 as a Potential Inductor in the Switch from Commensal to Pathogen in Oncogenic Bacterium Fusobacterium nucleatum.

Journal: Antioxidants (Basel, Switzerland)

Published: January 12, 2025

Clinical Benefits and Utility of Pretherapeutic DPYD and UGT1A1 Testing in Gastrointestinal Cancer: A Secondary Analysis of the PREPARE Randomized Clinical Trial.

Clinical Benefits and Utility of Pretherapeutic DPYD and UGT1A1 Testing in Gastrointestinal Cancer: A Secondary Analysis of the PREPARE Randomized Clinical Trial.

Journal: JAMA network open

Published: December 06, 2024

Impact of Vitamin D Levels on Progression-Free Survival and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Systematic Review and Meta-Analysis.

Impact of Vitamin D Levels on Progression-Free Survival and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Systematic Review and Meta-Analysis.

Journal: Cancers

Published: November 15, 2024

Proposal of model for personalized early adapted cancer screening in people living with HIV: experience of "Gaetano Martino" Hospital University of Messina.

Proposal of model for personalized early adapted cancer screening in people living with HIV: experience of "Gaetano Martino" Hospital University of Messina.

Journal: European review for medical and pharmacological sciences

Published: April 19, 2024

Implementing fencing as adapted physical activity in non-metastatic breast cancer patients: design and early rehabilitation strategy of the FENICE study protocol.

Implementing fencing as adapted physical activity in non-metastatic breast cancer patients: design and early rehabilitation strategy of the FENICE study protocol.

Journal: Frontiers in oncology

Published: April 17, 2024

Circulating vitamin D level before initiating chemotherapy impacts on the time-to-outcome in metastatic colorectal cancer patients: systematic review and meta-analysis.

Circulating vitamin D level before initiating chemotherapy impacts on the time-to-outcome in metastatic colorectal cancer patients: systematic review and meta-analysis.

Journal: Journal of translational medicine

Published: September 30, 2023

Implementation of pre-emptive testing of a pharmacogenomic panel in clinical practice: Where do we stand?

Implementation of pre-emptive testing of a pharmacogenomic panel in clinical practice: Where do we stand?

Journal: British journal of clinical pharmacology

Published: September 13, 2023

Cost-utility analysis and cross-country comparison of pharmacogenomics-guided treatment in colorectal cancer patients participating in the U-PGx PREPARE study.

Cost-utility analysis and cross-country comparison of pharmacogenomics-guided treatment in colorectal cancer patients participating in the U-PGx PREPARE study.

Journal: Pharmacological research

Published: July 27, 2023

LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring.

LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring.

Journal: Pharmaceutics

Published: April 18, 2023

Showing 1-12 of 30

Last Updated: 09/26/2026